Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of fermented mulberry leaves on growth performance, nutrient digestibility, diarrhea, and intestinal microecology in weaned piglets: a preliminary study.

Frontiers in veterinary science·2026
Same author

Association between <i>H. pylori</i> infection status, UBT-derived DOB level, and colorectal polyp detection.

Frontiers in oncology·2026
Same author

IL18 Works Like a Two-Side Coin in Acute Pancreatitis.

International journal of general medicine·2026
Same author

Association of TyG and TyG/HDL with <i>Helicobacter pylori</i> infection status and urea breath test load: a cross-sectional study.

Frontiers in medicine·2026
Same author

Low-dose rectal indomethacin to prevent post-ERCP pancreatitis: results of a large Chinese multicenter randomized noninferiority trial.

Endoscopy·2026
Same author

The ubiquitin-like protein FAT10 enhances the autophagy-mediated degradation of ZO-1 by stabilizing ATG3 to promote the lung metastasis of colon cancer.

Cellular oncology (Dordrecht, Netherlands)·2026

Related Experiment Video

Updated: May 28, 2026

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

Hypoxia, stem cells and bone tumor.

Wen Zeng1, Rong Wan, Yuehuan Zheng

  • 1Department of Orthopaedics, Institute of Traumatology and Orthopaedics, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, People's Republic of China.

Cancer Letters
|October 18, 2011
PubMed
Summary

Hypoxia, or low oxygen, significantly impacts bone tumor growth by influencing stem cells and their environment. Hypoxia-inducible factors (HIFs) are key regulators in this process, affecting bone tumorigenesis.

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Related Experiment Videos

Last Updated: May 28, 2026

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging
10:03

Bioengineering of Humanized Bone Marrow Microenvironments in Mouse and Their Visualization by Live Imaging

Published on: August 1, 2017

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Area of Science:

  • Oncology
  • Cell Biology
  • Biomedical Science

Background:

  • Normal oxygen levels are crucial for cellular functions and niche regulation.
  • Hypoxia is increasingly recognized for its role in normal development and disease, particularly in solid tumor growth.
  • Hypoxia-inducible factors (HIFs) are central mediators of cellular adaptation to low-oxygen conditions.

Purpose of the Study:

  • To review the critical role of HIFs in bone tumor formation.
  • To elucidate the interplay between hypoxia, stem cells, and their niches in bone tumorigenesis.

Main Methods:

  • Literature review focused on hypoxia, HIFs, stem cells, and bone cancer.
  • Analysis of existing research on the molecular mechanisms regulating bone tumorigenesis under hypoxic conditions.

Main Results:

  • HIFs are key regulators of cellular responses to hypoxia, significantly influencing bone tumor development.
  • The tumor microenvironment, including stem cells and their niches, is profoundly affected by hypoxic conditions, driving tumor progression.
  • Specific mechanisms by which hypoxia and HIFs modulate stem cell behavior in bone cancer were examined.

Conclusions:

  • Hypoxia and HIFs are critical determinants of bone tumorigenesis.
  • Targeting hypoxia and HIF pathways presents a potential therapeutic strategy for bone tumors.
  • Understanding the complex interactions within the hypoxic niche is essential for advancing bone cancer treatment.